Course offering number:0810-405
Course ID:
2118
Early Stage Clinical Studies for Drugs and Devices
October 23-24, 2008
New Brunswick, NJ
Dr. Shayne C. Gad; Principle of Gad Consulting Services
Dr. Shayne C. Gad has been the Principle of Gad Consulting
Services for 15 years. His 30 years of experience includes
safety assessment in the medical device, biotechnology,
pharmaceutical and chemical industries. He has published 36
books and more than 350 abstracts, articles, and chapters in
the fields of toxicology, statistics and safety assessment,
pharmaceutical and medical device development, and is on the
editorial boards of the Journal of Applied Toxicology, The
International Journal of Toxicology, the Journal of Inhalation
Toxicology and the Journal of Acute Toxicology.
He was Editor-in-Chief for Toxicology Methods, and has
successfully opened 87 INDs in the past 15 years. He
served on the Consumer Product Safety Commission
Toxicology Advisory Board, and numerous NIH review
committees and Advisory Boards.
Dr. Gad received his Ph.D in Pharmacology/Toxicology from
the University of Texas at Austin and is a Diplomate of the
American Board of Toxicology and a Fellow of the Academy of
Toxicologic Sciences. He is a Past President of the American
College of Toxicology, three SOT specialty sections and the
Roundtable of Toxicology Consultants.
|